11/12
01:20 pm
lbph
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, LBPH, ZUO on Behalf of Shareholders
Neutral
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, LBPH, ZUO on Behalf of Shareholders
11/12
08:30 am
lbph
Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)
Low
Report
Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)
11/7
04:18 pm
lbph
Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Low
Report
Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]
11/7
04:01 pm
lbph
Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Low
Report
Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
11/1
12:06 pm
lbph
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, LBPH, ZUO on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, LBPH, ZUO on Behalf of Shareholders
10/31
12:03 pm
lbph
LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc. - LBPH
Low
Report
LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc. - LBPH
10/22
11:38 am
lbph
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INSI, LBPH, NBR on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INSI, LBPH, NBR on Behalf of Shareholders
10/16
03:50 pm
lbph
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBPH, ARC, K, AFBI on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBPH, ARC, K, AFBI on Behalf of Shareholders
10/16
11:45 am
lbph
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBPH, YOTA, AG, GATO on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBPH, YOTA, AG, GATO on Behalf of Shareholders
10/16
11:28 am
lbph
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc. – LBPH
Low
Report
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc. – LBPH
10/16
07:41 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) was downgraded by analysts at Wedbush from a "strong-buy" rating to a "hold" rating.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) was downgraded by analysts at Wedbush from a "strong-buy" rating to a "hold" rating.
10/15
07:12 pm
lbph
LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc. - LBPH
Low
Report
LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc. - LBPH
10/15
04:00 pm
lbph
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc. - LBPH
Low
Report
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc. - LBPH
10/15
01:32 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock, down previously from $80.00.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock, down previously from $80.00.
10/15
10:38 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "hold" rating re-affirmed by analysts at Truist Financial Co.. They now have a $60.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "hold" rating re-affirmed by analysts at Truist Financial Co.. They now have a $60.00 price target on the stock.
10/15
10:07 am
lbph
Longboard Pharma's Lucrative Exit To Lundbeck Another Coup For Management [Seeking Alpha]
Low
Report
Longboard Pharma's Lucrative Exit To Lundbeck Another Coup For Management [Seeking Alpha]
10/15
09:17 am
lbph
Kuehn Law Encourages PRMW, FBMS, EVRI, and LBPH Investors to Contact Law Firm
Low
Report
Kuehn Law Encourages PRMW, FBMS, EVRI, and LBPH Investors to Contact Law Firm
10/14
07:31 pm
lbph
Wall Street sets new records as Nvidia and tech stocks soar [Yahoo! Finance]
Low
Report
Wall Street sets new records as Nvidia and tech stocks soar [Yahoo! Finance]
10/14
05:47 pm
lbph
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Longboard Pharmaceuticals, Inc.
Low
Report
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Longboard Pharmaceuticals, Inc.
10/14
05:19 pm
lbph
Wall Street sets new records as Nvidia and tech stocks soar [Fortune]
Low
Report
Wall Street sets new records as Nvidia and tech stocks soar [Fortune]
10/14
01:44 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $60.00 price target on the stock, up previously from $45.00.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $60.00 price target on the stock, up previously from $45.00.
10/14
11:16 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
10/14
08:08 am
lbph
Shareholder Alert: Ademi LLP Investigates Whether Longboard Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Low
Report
Shareholder Alert: Ademi LLP Investigates Whether Longboard Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public Shareholders
10/14
08:08 am
lbph
LBPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Longboard Pharmaceuticals, Inc. Is Fair to Shareholders
Low
Report
LBPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Longboard Pharmaceuticals, Inc. Is Fair to Shareholders
10/14
07:56 am
lbph
Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal [Yahoo! Finance Canada]
Low
Report
Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal [Yahoo! Finance Canada]